Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria

Diabetes

Volumn 43, Issue 8, 1994, Pages 1046-1051

  Taft, Jonathan L ^a   Nolan, Christopher J ^b   Yeung, Stella P ^b   Hewitson, Timothy D ^b   Martin, F Ian R ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; CHLOROTHIAZIDE; CREATINE KINASE; ENALAPRIL; HEMOGLOBIN A1C; PRAZOSIN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BIOPSY; KIDNEY FUNCTION; MORPHOMETRICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; PROTEINURIA; RENOVASCULAR HYPERTENSION;

EID: 0027930904     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.43.8.1046     Document Type: Article

References (25)

1. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T: Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496-501, 1983
2. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-300, 1984
3. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR: The changing natural history of nephropathy in type 1 diabetes. Am J Med 78:785-794, 1985
4. Borch-Johnsen K, Kreiner S: Proteinuria: value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J 294:1651-1654, 1987
5. Deckert T, Poulsen JE: Diabetic nephropathy, fault or destiny. Diabetologia 21:178-183, 1981
6. Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Dr Med J 285:685-168, 1982
7. Parving HH, Anderson AR, Smidt UN, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet i:1175-1179, 1983
8. Nyberg G, Blohme G, Norden G: Impact of metabolic control on progression of clinical diabetic nephropathy. Diabetologia 30:82-86, 1987
9. Mathieson ER, Borch-Johnsen K, Jensen DV, Deckert T: Improved survival in patients with diabetic nephropathy. Diabetologia 32:884-886, 1989
10. McCance DR, Hadden DR, Atkinson AB, Johnston H, Kennedy L: The relationship between long-term glycemic control and diabetic nephropathy. Q J Med 297:53-61, 1992
11. Rossing P, Hommel E, Smidt A, Parving H-H: Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM. Diabetes 42:715-717, 1993
12. Lewis ES, Hunsicker LG, Bain RP and Rohde RD, for the Collaborative Study Group: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
13. Bjork S, Mulec H, Johnsen SA, Norden G, Aurell M: Renal protective effect of enalapril in diabetic nephropathy Br Med J 304:339-343, 1992
14. Mimran A, Insua A, Ribstein J, Bringer J, Monnier L: Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Diabetes Care 11:850-853, 1988
15. Melbourne Diabetic Nephropathy Study Group: Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Br Med J 302:210-216, 1991
16. Bakris GL: Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med 112:707-708, 1990
17. Baba T, Murabayashi S, Takebe K: Comparison of the renal effects of angiotensin-converting enzyme inhibitor and calcium antagonist in hypertensive type 2 diabetic patients with microalbuminuria. Diabetologia 32:40-44, 1989
18. Parving H-H, Rossing P, Hommel E, Smidt UM: Renal protective effects of captopril and metoprolol in diabetic nephropathy (Abstract). Diabetologia 35 (Suppl. 1):A148, 1992
19. Gundersen HJG, Osterby R: Glomerular size and structure in diabetes mellitus. ii. Late abnormalities. Diabetologia 13:43-48, 1977
20. Mauer SM, Steffes MW, Sutherland DE, Brown DM, Goetz FC: Structural functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
21. Osterby R, Parving H-H, Hommel E, Jorgensen HE, Lokkegaard II: Glomerular structure and function in diabetic nephropathy: early to advanced stages. Diabetes 39:1057-1063, 1990
22. Steffes MW, Osterby R, Chavers B, Mauer SM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38:1077-1081, 1989
23. Bohle A, Christ H, Grand KE, Mackensen S: The role of the interstitium of the renal cortex in renal disease. Contrib Nephrol 10:109-114, 1979
24. Bader R, Bader H, Grund KE, Mackensen S, Christ H, Bohle A: Structure and function of the kidney in diabetic glomerulosclerosis correlation between morphological and functional parameters. Pathol Res Pract 167:204-216, 1980
25. Lane PH, Steffes MW, Fioretto P, Mauer SM: Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 43:661-667, 1993